Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Ketamine by Neurocentrx Pharma for Bipolar Disorder (Manic Depression): Likelihood of Approval
Ketamine is under clinical development by Neurocentrx Pharma and currently in Phase I for Bipolar Disorder (Manic Depression). According to...
Ketamine by Psycheceutical for Post-Traumatic Stress Disorder (PTSD): Likelihood of Approval
Ketamine is under clinical development by Psycheceutical and currently in Phase I for Post-Traumatic Stress Disorder (PTSD). According to GlobalData,...
Ketamine by NRX Pharmaceuticals for Bipolar Disorder (Manic Depression): Likelihood of Approval
Ketamine is under clinical development by NRX Pharmaceuticals and currently in Phase III for Bipolar Disorder (Manic Depression). According to...